Lv1
18 积分 2025-02-11 加入
HBO1, a MYSTerious KAT and its links to cancer
3天前
已完结
An efficient high-throughput screening method for MYST family acetyltransferases, a new class of epigenetic drug targets
3天前
已完结
Inhibitors of histone acetyltransferases KAT6A/B induce senescence and arrest tumour growth
3天前
已完结
Discovery and Characterization of BAY-184: A New Potent and Selective Acylsulfonamide-Benzofuran In Vivo-Active KAT6AB Inhibitor
3天前
已完结
Discovery and Characterization of BAY-184: A New Potent and Selective Acylsulfonamide-Benzofuran In Vivo-Active KAT6AB Inhibitor
13天前
已完结
Dancing with KAT6A: Current advances and therapeutic potential in oncology of KAT6A inhibitors
13天前
已完结
Dual-target inhibitors based on ERα: Novel therapeutic approaches for endocrine resistant breast cancer
16天前
已完结
OP-1250: A potent orally available complete antagonist of estrogen receptor-mediated signaling that shrinks wild type and mutant breast tumors
23天前
已完结
Pharmacological Inhibition of CBP/p300 Blocks Estrogen Receptor Alpha (ERα) Function through Suppressing Enhancer H3K27 Acetylation in Luminal Breast Cancer
1个月前
已完结
Discovery of CBPD-409 as a Highly Potent, Selective, and Orally Efficacious CBP/p300 PROTAC Degrader for the Treatment of Advanced Prostate Cancer
1个月前
已完结
皖公网安备34019202002308
